Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Kojima, Naoya ^a   Ishii, Mariko ^a   Kawauchi, Yoko ^a   Takagi, Hideaki ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; LIPOSOME; MANNOSE OLIGOSACCHARIDE; IMMUNOLOGICAL ADJUVANT; MANNOSE; VACCINE;

CELL ACTIVATION; CELL STIMULATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE CONTROL; HUMAN; IN VIVO STUDY; LYMPHOID TISSUE; MOLECULE; NATURAL KILLER T CELL; NONHUMAN; PHAGOCYTE; PROTEIN EXPRESSION; REVIEW; TH1 CELL; VACCINATION; ANIMAL; ANTIGEN PRESENTATION; CATTLE; CHEMISTRY; DENDRITIC CELL; DRUG EFFECT; IMMUNOLOGY; MOUSE; PHAGOCYTOSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; CATTLE; DENDRITIC CELLS; HUMANS; IMMUNITY, CELLULAR; LIPOSOMES; MANNOSE; MICE; PHAGOCYTOSIS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; VACCINES;

EID: 84886463948     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/562924     Document Type: Review

References (77)

1. Palucka K., Banchereau J., Dendritic cells: a link between innate and adaptive immunity. Journal of Clinical Immunology 1999 19 1 12 25 2-s2.0-0032956004 (Pubitemid 29113329)
2. Pulendran B., Smith J. L., Caspary G., Brasel K., Pettit D., Maraskovsky E., Maliszewski C. R., Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proceedings of the National Academy of Sciences of the United States of America 1999 96 3 1036 1041 2-s2.0-0033514364
3. Banchereau J., Steinman R. M., Dendritic cells and the control of immunity. Nature 1998 392 6673 245 252 2-s2.0-0032546352 10.1038/32588 (Pubitemid 28155090)
4. O'Hagan D. T., Valiante N. M., Recent advances in the discovery and delivery of vaccine adjuvants. Nature Reviews Drug Discovery 2003 2 9 727 735 2-s2.0-0142058176 (Pubitemid 37361788)
5. Tacken P. J., Torensma R., Figdor C. G., Targeting antigens to dendritic cells in vivo. Immunobiology 2006 211 6-8 599 608 2-s2.0-33747362405 10.1016/j.imbio.2006.05.021
6. Morón G., Dadaglio G., Leclerc C., New tools for antigen delivery to the MHC class I pathway. Trends in Immunology 2004 25 2 92 97 2-s2.0-0842303169 10.1016/j.it.2003.11.008 (Pubitemid 38167490)
7. Heijnen I. A. F. M., Van Vugt M. J., Fanger N. A., Graziano R. F., De Wit T. P. M., Hofhuis F. M. A., Guyre P. M., Capel P. J. A., Verbeek J. S., Van De Winkel J. G. J., Antigen targeting to myeloid-specific human Fc γ RI/CD64 triggers enhanced antibody responses in transgenic mice. Journal of Clinical Investigation 1996 97 2 331 338 2-s2.0-13344259328 (Pubitemid 26039395)
8. Liu Y., Gao X., Masuda E., Redecha P. B., Blank M. C., Pricop L., Regulated expression of Fc γ R in human dendritic cells controls cross-presentation of antigen-antibody complexes. Journal of Immunology 2006 177 12 8440 8447 2-s2.0-33845411595 (Pubitemid 44893806)
9. Mende I., Hoffmann P., Wolf A., Lutterbüse R., Kopp E., Baeuerle P. A., de Baey A., Kufer P., Highly efficient antigen targeting to M-DC8+ dendritic cells via Fc γ RIII/CD16-specific antibody conjugates. International Immunology 2005 17 5 539 547 2-s2.0-21244473186 10.1093/intimm/dxh232 (Pubitemid 41417851)
10. Guermonprez P., Khelef N., Blouin E., Rieu P., Ricciardi-Castagnoli P., Guiso N., Ladant D., Leclerc C., The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the α M β 2 integrin (CD11b/CD18). Journal of Experimental Medicine 2001 193 9 1035 1044 2-s2.0-0035821250 10.1084/jem.193.9.1035 (Pubitemid 32436197)
11. Storni T., Kündig T. M., Senti G., Johansen P., Immunity in response to particulate antigen-delivery systems. Advanced Drug Delivery Reviews 2005 57 3 333 355 2-s2.0-9344271546 10.1016/j.addr.2004.09.008 (Pubitemid 39555501)
12. Men Y., Tamber H., Audran R., Gander B., Corradin G., Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres. Vaccine 1997 15 12-13 1405 1412 2-s2.0-0030883026 10.1016/S0264-410X(97)00047-9 (Pubitemid 27397821)
13. Wassef N. M., Alving C. R., Richards R. L., Liposomes as carriers for vaccines. ImmunoMethods 1994 4 3 217 222 2-s2.0-0027944114 10.1006/immu.1994. 1023 (Pubitemid 24318704)
14. Altin J. G., Van Broekhoven C. L., Parish C. R., Targeting dendritic cells with antigen-containing liposomes: antitumour immunity. Expert Opinion on Biological Therapy 2004 4 11 1735 1747 2-s2.0-8744223031 10.1517/14712598.4.11. 1735 (Pubitemid 39518107)
15. Van Broekhoven C. L., Parish C. R., Demangel C., Britton W. J., Altin J. G., Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Research 2004 64 12 4357 4365 2-s2.0-3042523520 10.1158/0008-5472.CAN-04-0138 (Pubitemid 38802444)
16. + T-cell immune response and protect hamsters against visceral leishmaniasis. Vaccine 2006 24 11 1800 1810 2-s2.0-32544433906 10.1016/j.vaccine.2005.10.025 (Pubitemid 43238261)
17. Chikh G., Schutze-Redelmeir M.-P., Liposomal delivery of CTL epitopes to dendritic cells. Bioscience Reports 2002 22 2 339 353 2-s2.0-0036555126 10.1023/A:1020151025412 (Pubitemid 35222740)
18. Nakanishi T., Kunisawa J., Hayashi A., Tsutsumi Y., Kubo K., Nakagawa S., Nakanishi M., Tanaka K., Mayumi T., Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins. Journal of Controlled Release 1999 61 1-2 233 240 2-s2.0-0032816878 10.1016/S0168-3659(99)00097-8 (Pubitemid 29406095)
19. Guy B., Pascal N., Françon A., Bonnin A., Gimenez S., Lafay-Vialon E., Trannoy E., Haensler J., Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine. Vaccine 2001 19 13-14 1794 1805 2-s2.0-0035825581 10.1016/S0264-410X(00)00386-8 (Pubitemid 32175742)
20. Park J. W., Kirpotin D. B., Hong K., Shalaby R., Shao Y., Nielsen U. B., Marks J. D., Papahadjopoulos D., Benz C. C., Tumor targeting using anti-her2 immunoliposomes. Journal of Controlled Release 2001 74 1-3 95 113 2-s2.0-0035816199 10.1016/S0168-3659(01)00315-7 (Pubitemid 32727613)
21. Gieseler R. K., Marquitan G., Hahn M. J., Perdon L. A., Driessen W. H. P., Sullivan S. M., Scolaro M. J., DC-SIGN-specific liposomal targeting and selective intracellular compound delivery to human myeloid dendritic cells: implications for HIV disease. Scandinavian Journal of Immunology 2004 59 5 415 424 2-s2.0-2642534487 10.1111/j.0300-9475.2004.01431.x (Pubitemid 38725550)
22. Shimizu Y., Yamakami K., Gomi T., Nakata M., Asanuma H., Tadakuma T., Kojima N., Protection against Leishmania major infection by oligomannose-coated liposomes. Bioorganic and Medicinal Chemistry 2003 11 7 1191 1195 2-s2.0-0037375845 10.1016/S0968-0896(02)00644-2 (Pubitemid 36293515)
23. Nishikawa Y., Zhang H., Ikehara Y., Kojima N., Xuan X., Yokoyama N., Immunization with oligomannose-coated liposome-entrapped dense granule protein 7 protects dams and offspring from Neospora caninum infection in mice. Clinical and Vaccine Immunology 2009 16 6 792 797 2-s2.0-67249121072 10.1128/CVI.00032-09
24. Kojima N., Biao L., Nakayama T., Ishii M., Ikehara Y., Tsujimura K., Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity. Journal of Controlled Release 2008 129 1 26 32 2-s2.0-44649161802 10.1016/j.jconrel.2008.03.023
25. Ishii M., Koyama A., Iseki H., Narumi H., Yokoyama N., Kojima N., Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice. International Immunopharmacology 2010 10 9 1041 1046 2-s2.0-77955920793 10.1016/j.intimp.2010. 06.003
26. Janeway C. A. Jr., Medzhitov R., Innate immune recognition. Annual Review of Immunology 2002 20 197 216 2-s2.0-0036212849 10.1146/annurev.immunol.20. 083001.084359 (Pubitemid 34293424)
27. Kawai T., Akira S., Pathogen recognition with Toll-like receptors. Current Opinion in Immunology 2005 17 4 338 344 2-s2.0-20544474210 10.1016/j.coi.2005.02.007 (Pubitemid 40848534)
28. McGreal E. P., Martinez-Pomares L., Gordon S., Divergent roles for C-type lectins expressed by cells of the innate immune system. Molecular Immunology 2004 41 11 1109 1121 2-s2.0-5144228482 10.1016/j.molimm.2004.06.013 (Pubitemid 39345392)
29. Geijtenbeek T. B. H., Van Vliet S. J., Engering A., 'T Hart B. A., Van Kooyk Y., Self- and nonself-recognition by C-type lectins on dendritic cells. Annual Review of Immunology 2004 22 33 54 2-s2.0-2542474306 10.1146/annurev. immunol.22.012703.104558 (Pubitemid 38680417)
30. Robinson M. J., Sancho D., Slack E. C., LeibundGut-Landmann S., Sousa C. R., Myeloid C-type lectins in innate immunity. Nature Immunology 2006 7 12 1258 1265 2-s2.0-33846307747 10.1038/ni1417 (Pubitemid 46111243)
31. van Kooyk Y., C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochemical Society Transactions 2008 36 6 1478 1481 2-s2.0-59149106509 10.1042/BST0361478
32. Mahnke K., Guo M., Lee S., Sepulveda H., Swain S. L., Nussenzweig M., Steinman R. M., The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. Journal of Cell Biology 2000 151 3 673 683 2-s2.0-0034735552 10.1083/jcb.151.3.673
33. Engering A., Geijtenbeek T. B. H., Van Vliet S. J., Wijers M., Van Liempt E., Demaurex N., Lanzavecchia A., Fransen J., Figdor C. G., Piguet V., Van Kooyk Y., The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. Journal of Immunology 2002 168 5 2118 2126 2-s2.0-0036499125 (Pubitemid 34171810)
34. + T cell tolerance. Journal of Experimental Medicine 2002 196 12 1627 1638 2-s2.0-0037122011 10.1084/jem.20021598 (Pubitemid 36026474)
35. Turner M. W., Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunology Today 1996 17 11 532 540 2-s2.0-0030297443 10.1016/0167-5699(96)10062-1 (Pubitemid 26373253)
36. Geijtenbeek T. B. H., Torensma R., Van Vliet S. J., Van Duijnhoven G. C. F., Adema G. J., Van Kooyk Y., Figdor C. G., Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000 100 5 575 585 2-s2.0-0034598934
37. Park C. G., Takahara K., Umemoto E., Yashima Y., Matsubara K., Matsuda Y., Clausen B. E., Inaba K., Steinman R. M., Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. International Immunology 2001 13 10 1283 1290 2-s2.0-0034772132 (Pubitemid 32994528)
38. Stambach N. S., Taylor M. E., Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cell. Glycobiology 2003 13 5 401 410 2-s2.0-0038394449 10.1093/glycob/cwg045 (Pubitemid 36592327)
39. McGreal E. P., Rosas M., Brown G. D., Zamze S., Wong S. Y. C., Gordon S., Martinez-Pomares L., Taylor P. R., The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology 2006 16 5 422 430 2-s2.0-33646126940 10.1093/glycob/cwj077
40. Singh S. K., Stephani J., Schaefer M., Kalay H., García-Vallejo J. J., den Haan J., Saeland E., Sparwasser T., van Kooyk Y., Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Molecular Immunology 2009 47 2-3 164 174 2-s2.0-70450277084 10.1016/j.molimm.2009.09.026
41. Espuelas S., Haller P., Schuber F., Frisch B., Synthesis of an amphiphilic tetraantennary mannosyl conjugate and incorporation into liposome carriers. Bioorganic and Medicinal Chemistry Letters 2003 13 15 2557 2560 2-s2.0-0038648179 10.1016/S0960-894X(03)00472-4 (Pubitemid 36830772)
42. Espuelas S., Thumann C., Heurtault B., Schuber F., Frisch B., Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes. Bioconjugate Chemistry 2008 19 12 2385 2393 2-s2.0-58149085979 10.1021/bc8002524
43. White K. L., Rades T., Hook S., Furneaux R. H., Tyler P. C., Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells. Journal of Pharmacy and Pharmacology 2006 58 6 729 737 2-s2.0-33744811685 10.1211/jpp.58.6.0003 (Pubitemid 43836160)
44. Ikehara Y., Niwa T., Biao L., Ikehara S. K., Ohashi N., Kobayashi T., Shimizu Y., Kojima N., Nakanishi H., A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Research 2006 66 17 8740 8748 2-s2.0-33749008542 10.1158/0008-5472.CAN-06-0470 (Pubitemid 44449191)
45. Takagi H., Numazaki M., Kajiwara T., Abe Y., Ishii M., Kato C., Kojima N., Cooperation of specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) and complement receptor type 3 (CR3) in the uptake of oligomannose-coated liposomes by macrophages. Glycobiology 2009 19 3 258 266 2-s2.0-58949096685 10.1093/glycob/cwn128
46. Abe Y., Kuroda Y., Kuboki N., Matsushita M., Yokoyama N., Kojima N., Contribution of complement component C3 and complement receptor type 3 to carbohydrate-dependent uptake of oligomannose-coated liposomes by peritoneal macrophages. Journal of Biochemistry 2008 144 5 563 570 2-s2.0-55349117144 10.1093/jb/mvn101
47. Kang Y.-S., Do Y., Lee H.-K., Park S. H., Cheong C., Lynch R. M., Loeffler J. M., Steinman R. M., Park C. G., A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 2006 125 1 47 58 2-s2.0-33646005763 10.1016/j.cell.2006.01.046
48. Takagi H., Furuya N., Kojima N., Preferential production of IL-12 by peritoneal macrophages activated by liposomes prepared from neoglycolipids containing oligomannose residues. Cytokine 2007 40 3 241 250 2-s2.0-36749084648 10.1016/j.cyto.2007.10.005 (Pubitemid 350213437)
49. Ishii M., Kato C., Hakamata A., Kojima N., Targeting with oligomannose-coated liposomes promotes maturation and splenic trafficking of dendritic cells in the peritoneal cavity. International Immunopharmacology 2011 11 2 164 171 2-s2.0-79151481948 10.1016/j.intimp.2010.11.011
50. Martín-Fontecha A., Sebastiani S., Höpken U. E., Uguccioni M., Lipp M., Lanzavecchia A., Sallusto F., Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. Journal of Experimental Medicine 2003 198 4 615 621 2-s2.0-0042922810 10.1084/jem.20030448 (Pubitemid 37040395)
51. Kojima N., Kato C., Igarashi M., Ishii M., Development of peritoneal macrophage along a dendritic cell lineage in response to uptake of oligomannose-coated liposomes. Cellular Immunology 2011 271 2 335 341 2-s2.0-80054047832 10.1016/j.cellimm.2011.07.013
52. Leen A. M., Rooney C. M., Foster A. E., Improving T cell therapy for cancer. Annual Review of Immunology 2007 25 243 265 2-s2.0-34247881794 10.1146/annurev.immunol.25.022106.141527 (Pubitemid 46697909)
53. Ikehara Y., Shiuchi N., Kabata-Ikehara S., Nakanishi H., Yokoyama N., Takagi H., Nagata T., Koide Y., Kuzushima K., Takahashi T., Tsujimura K., Kojima N., Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells. Cancer Letters 2008 260 1-2 137 145 2-s2.0-38349056673 10.1016/j.canlet.2007.10.038
54. Shimizu Y., Takagi H., Nakayama T., Yamakami K., Tadakuma T., Yokoyama N., Kojima N., Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages. Parasite Immunology 2007 29 5 229 239 2-s2.0-34247175385 10.1111/j.1365-3024. 2007.00937.x (Pubitemid 46596114)
55. Lehmann J., Enssle K.-H., Lehmann I., Emmendörfer A., Lohmann-Matthes M.-L., The capacity to produce IFN- γ rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice. Journal of Interferon and Cytokine Research 2000 20 1 63 77 2-s2.0-0033974189 10.1089/107999000312748 (Pubitemid 30067490)
56. Himmelrich H., Launois P., Maillard I., Biedermann T., Tacchini-Cottier F., Locksley R. M., Röcken M., Louis J. A., In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. Journal of Immunology 2000 164 9 4819 4825 2-s2.0-0034193027 (Pubitemid 30238085)
57. Godfrey D. I., Hammond K. J. L., Poulton L. D., Smyth M. J., Baxter A. G., NKT cells: facts, functions and fallacies. Immunology Today 2000 21 11 573 583 2-s2.0-0033662145 10.1016/S0167-5699(00)01735-7
58. Taniguchi M., Harada M., Kojo S., Nakayama T., Wakao H., The regulatory role of V α 14 NKT cells in innate and acquired immune response. Annual Review of Immunology 2003 21 483 513 2-s2.0-0038228956 10.1146/annurev.immunol. 21.120601.141057 (Pubitemid 37174539)
59. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., Taniguchi M., CD1d-restricted and TCR-mediated activation of V(α)14 NKT cells by glycosylceramides. Science 1997 278 5343 1626 1629 2-s2.0-0030696696 10.1126/science.278.5343.1626 (Pubitemid 27516282)
60. Ishii M., Kojima N., Effective stimulation of invariant natural killer T cells by oligomannose-coated liposomes. International Immunopharmacology 2013 15 4 685 692
61. Crowe N. Y., Uldrich A. P., Kyparissoudis K., Hammond K. J. L., Hayakawa Y., Sidobre S., Keating R., Kronenberg M., Smyth M. J., Godfrey D. I., Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. Journal of Immunology 2003 171 8 4020 4027 2-s2.0-0141958207 (Pubitemid 37238677)
62. Zhang H., Nishikawa Y., Yamagishi J., Zhou J., Ikehara Y., Kojima N., Yokoyama N., Xuan X., Neospora caninum: application of apical membrane antigen 1 encapsulated in the oligomannose-coated liposomes for reduction of offspring mortality from infection in BALB/c mice. Experimental Parasitology 2010 125 2 130 136 2-s2.0-77951896694 10.1016/j.exppara.2010.01.008
63. Nishimura M., Kohara J., Kuroda Y., Hiasa J., Tanaka S., Muroi Y., Kojima N., Furuoka H., Nishikawa Y., Oligomannose-coated liposome-entrapped dense granule protein 7 induces protective immune response to Neospora caninum in cattle. Vaccine 2013 31 35 3528 3535
64. Pene J., Rousset F., Briere F., Chretien I., Bonnefoy J.-Y., Spits H., Yokota T., Arai N., Arai K., Banchereau J., De Vries J., IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons γ and α and prostaglandin E2. Proceedings of the National Academy of Sciences of the United States of America 1988 85 18 6880 6884 2-s2.0-1542396389
65. Seder R. A., Paul W. E., Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annual Review of Immunology 1994 12 635 673 2-s2.0-0028201726 (Pubitemid 24140427)
66. Snapper C. M., Paul W. E., Interferon- γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987 236 4804 944 947 2-s2.0-0023197097 (Pubitemid 17107942)
67. Ishii M., Kojima N., Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization. Glycoconjugate Journal 2010 27 1 115 123 2-s2.0-77949269003 10.1007/s10719-009-9263-8
68. Kawakita A., Shirasaki H., Yasutomi M., Tokuriki S., Mayumi M., Naiki H., Ohshima Y., Immunotherapy with oligomannose-coated liposomes ameliorates allergic symptoms in a murine food allergy model. Allergy 2012 67 3 371 379 2-s2.0-84857194110 10.1111/j.1398-9995.2011.02777.x
69. Curiel T. J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J. R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M. L., Knutson K. L., Chen L., Zou W., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine 2004 10 9 942 949 2-s2.0-4644237613 10.1038/nm1093 (Pubitemid 39273735)
70. Kozako T., Hirata S., Shimizu Y., Satoh Y., Yoshimitsu M., White Y., Lemonnier F., Shimeno H., Soeda S., Arima N., Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant. FEBS Journal 2011 278 8 1358 1366 2-s2.0-79953676568 10.1111/j.1742-4658.2011.08055.x
71. Mizuuchi M., Hirohashi Y., Torigoe T., Kuroda T., Yasuda K., Shimizu Y., Saito T., Sato N., Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses. Experimental and Molecular Pathology 2012 92 1 185 190 2-s2.0-84857539946 10.1016/j.yexmp.2011.10.002
72. Owais M., Masood A. K., Agrewala J. N., Bisht D., Gupta C. M., Use of liposomes as an immunopotentiating delivery system: in perspective of vaccine development. Scandinavian Journal of Immunology 2001 54 1-2 125 132 2-s2.0-0034959126 10.1046/j.1365-3083.2001.00944.x (Pubitemid 32592337)
73. Ansari M. A., Zubair S., Mahmood A., Gupta P., Khan A. A., Gupta U. D., Arora A., Owais M., RD antigen based nanovaccine imparts long term protection by inducing memory response against experimental murine tuberculosis. PLoS ONE 2011 6 8 2-s2.0-80051644799 10.1371/journal.pone.0022889 e22889
74. Hirai M., Minematsu H., Kondo N., Oie K., Igarashi K., Yamazaki N., Accumulation of liposome with Sialyl Lewis X to inflammation and tumor region: application to in vivo bio-imaging. Biochemical and Biophysical Research Communications 2007 353 3 553 558 2-s2.0-33846025384 10.1016/j.bbrc.2006.12.060 (Pubitemid 46048704)
75. Chen W. C., Completo G. C., Sigal D. S., Crocker P. R., Saven A., Paulson J. C., In vivo targeting of B-cell lymphoma with glycan ligands of CD22. Blood 2010 115 23 4778 4786 2-s2.0-77954729240 10.1182/blood-2009-12-257386
76. Chen W. C., Kawasaki N., Nycholat C. M., Han S., Pilotte J., Crocker P. R., Paulson J. C., Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169. PLoS ONE 2012 7 6 e39039
77. Kawasaki N., Vela J. L., Nycholat C. M., Rademacher C., Khurana A., van Rooijen N., Crocker P. R., Kronenberg M., Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation. Proceedings of the National Academy of Sciences 2013 110 19 7826 7831